期刊
CURRENT OSTEOPOROSIS REPORTS
卷 19, 期 4, 页码 462-479出版社
SPRINGER
DOI: 10.1007/s11914-020-00629-9
关键词
Osteoporosis; Osteopathy; Type 1 diabetes; Type 2 diabetes; Gut microbiota
The review highlights the increased risk of osteopathogenesis and skeletal fragility in patients with diabetes mellitus, and suggests that the gut microbiota may play a role in the pathology of both diseases. Future studies should focus on the involvement of gut microbiota in both diabetes and osteopathy.
Purpose of Review Patients with diabetes mellitus (DM) are at increased risk of developing osteopathogenesis and skeletal fragility. The role of the gut microbiota in both DM and osteopathy is not fully explored and may be involved in the pathology of both diseases. Recent Findings Gut microbiota alterations have been observed in DM and osteopathogenic disorders as compared with healthy controls, such as significantly lower abundance of Prevotella and higher abundance of Lactobacillus, with a diminished bacterial diversity. Other overlapping gastro-intestinal features include the loss of intestinal barrier function with translocation of bacterial metabolites to the blood stream, induction of immunological deficits and changes in hormonal and endocrinal signalling, which may lead to the development of diabetic osteopathy. Signalling pathways involved in both DM and osteopathy are affected by gut bacteria and their metabolites. Future studies should focus on gut microbiota involvement in both diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据